Kryxana 200mg (Ribociclib) is an anticancer medicine used to treat breast cancer in postmenopausal women. It inhibits the growth of cancer cells prevents it from spreading to other parts of the body.
Manufacturer : Novartis AG.
Strengths available : 200mg
Storage : Store between 20 °C - 25 °C
Dosage :
Usual Adult Dose for Breast Cancer
600 mg orally once a day for 21 consecutive days followed by 7 days off treatment for a complete cycle of 28 days.
Comments: Refer to the manufacturer product information for dosing and administration recommendations for the co-administered aromatase inhibitor (e.g., letrozole).
Use: In combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HE`R2)-negative advanced or metastatic breast cancer.
Most common side effects are Fatigue, diarrhea, headache, back pain, nausea, vomiting, or loss of appetite
Pack of 21 Film coated tablets
Mehan Biosciences is a WHO GDSP approved & licensed Pharmaceutical stockist/wholesaler/distributor/exporter/importer of KRYXANA Olaparib 200mg Tablets based in India - To buy KRYXANA Olaparib 200mg Tablets or know its cost price contact us here.
We supply & sell KRYXANA Olaparib 200mg Tablets for Reference Listed Drugs, Government Tenders, Shortage Lists, Emergency Imports, Name Patient Drugs, Comparator Drug Studies, Un-licensed Importation, clinical trial samples & Bio-Similars.
At MBS, we acknowledge the critical role that reliable sourcing and timely delivery play in the healthcare industry. MBS is your trusted partner in pharmaceutical supply chain management.